Biochemically recurrent prostate cancer: 68Ga-RM2 (formerly known as 68Ga-Bombesin or BAY86-7548) PET/MRI is superior to conventional imaging

被引:0
|
作者
Iagaru, Andrei [2 ]
Minamimoto, Ryogo [2 ]
Loening, Andreas [2 ]
Mueller, Andre [1 ]
Berndt, Mathias [1 ]
Stephens, Andrew [1 ]
Vasanawala, Shreyas [2 ]
机构
[1] Piramal Imaging GmbH, Berlin, Germany
[2] Stanford Univ, Stanford, CA 94305 USA
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
466
引用
收藏
页数:2
相关论文
共 50 条
  • [1] PROSPECTIVE STUDY OF 68GA-RM2 PET/MRI IN PATIENTS WITH BIOCHEMICALLY RECURRENT PROSTATE CANCER AND NEGATIVE CONVENTIONAL IMAGING
    Baratto, Lucia
    Song, Hong
    Duan, Heying
    Moradi, Farshad
    Davidzon, Guido
    Iagaru, Andrei
    JOURNAL OF UROLOGY, 2021, 206 : E1178 - E1178
  • [2] In Vivo Imaging of Prostate Cancer Using [68Ga]-Labeled Bombesin Analog BAY86-7548
    Kahkonen, Esa
    Jambor, Ivan
    Kemppainen, Jukka
    Lehtio, Kaisa
    Gronroos, Tove J.
    Kuisma, Anna
    Luoto, Pauliina
    Sipila, Henri J.
    Tolvanen, Tuula
    Alanen, Kalle
    Silen, Jonna
    Kallajoki, Markku
    Roivainen, Anne
    Schaefer, Niklaus
    Schibli, Roger
    Dragic, Martina
    Johayem, Anass
    Valencia, Ray
    Borkowski, Sandra
    Minn, Heikki
    CLINICAL CANCER RESEARCH, 2013, 19 (19) : 5434 - 5443
  • [3] A prospective study of 68Ga-RM2 PET/MRI in patients with biochemically recurrent prostate cancer and negative conventional imaging.
    Baratto, Lucia
    Song, Hong
    Duan, Heying
    Aparici, Carina Mari
    Davidzon, Guido
    Moradi, Farshad
    Srinivas, Sandy
    Iagaru, Andrei
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [4] 68Ga-RM2 PET/MRI Detection of Recurrent Prostate Cancer in Patients with Negative Conventional Imaging
    Baratto, L.
    Duan, H.
    Harrison, C.
    Mari, C.
    Davidzon, G.
    Yohannan, T.
    Iagaru, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S151 - S152
  • [5] 68Ga-RM2 PET/MRI Detection of Recurrent Prostate Cancer in Patients with Negative Conventional Imaging
    Baratto, Lucia
    Harrison, Caitlyn
    Davidzon, Guido
    Yohannan, Tommy
    Iagaru, Andrei
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59
  • [6] 68Ga-DOTA-Bombesin (68Ga-RM2 or 68Ga-Bombesin) PET versus 68Ga-PSMA PET: A pilot prospective evaluation in patients with biochemical recurrence of prostate cancer.
    Iagaru, Andrei
    Minamimoto, Ryogo
    Hancock, Steven Lee
    Mittra, Erik
    Loening, Andreas
    Vasanawala, Shreyas
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [7] Detection of Recurrent Prostate Cancer Using 68Ga-RM2 PET/MRI in Patients with Negative Conventional Imaging
    Harrison, Caitlyn
    Sonni, Ida
    Loening, Andreas
    Vasanawala, Shreyas
    Lagaru, Andrei
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58
  • [8] Pilot Comparison of 68Ga-RM2 PET and 68Ga-PSMA-11 PET in Patients with Biochemically Recurrent Prostate Cancer
    Minamimoto, Ryogo
    Hancock, Steven
    Schneider, Bernadette
    Chin, Frederick T.
    Jamali, Mehran
    Loening, Andreas
    Vasanawala, Shreyas
    Gambhir, Sanjiv Sam
    Iagaru, Andrei
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57 (04) : 557 - 562
  • [9] INTERIM ANALYSIS RESULTS OF A PROSPECTIVE STUDY OF 68GA-RM2 PET/MRI IN PATIENTS WITH BIOCHEMICALLY RECURRENT PROSTATE CANCER AND NEGATIVE CONVENTIONAL IMAGING
    Baratto, Lucia
    Song, Hong
    Duan, Heying
    Aparici, Carina Mari
    Hatami, Negin
    Davidzon, Guido
    Moradi, Farshad
    Iagaru, Andrei
    JOURNAL OF UROLOGY, 2020, 203 : E1118 - E1118
  • [10] Preliminary Results of a Prospective Study of 68Ga-RM2 PET/MRI for Detection of Recurrent Prostate Cancer in Patients with Negative Conventional Imaging
    Baratto, Lucia
    Duan, Heying
    Harrison, Caitlyn
    Hatami, Negin
    Aparici, Carina Mari
    Davidzon, Guido
    Yohannan, Tommy
    Iagaru, Andrei
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60